Editorial: Clinical phytopharmacology.
作者信息
Willcox Merlin L, Tai Chi-Jung, Chattopadhyay Kaushik, Hu Xiao-Yang, Heinrich Michael
机构信息
Primary Care Research Centre, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Department of Family Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
出版信息
Front Pharmacol. 2024 Jan 15;14:1353483. doi: 10.3389/fphar.2023.1353483. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Clinical phytopharmacology.社论：临床植物药理学
Front Pharmacol. 2024 Jan 15;14:1353483. doi: 10.3389/fphar.2023.1353483. eCollection 2023.
2
From the CONSORT to the ConPhyMP statement and beyond-how to ascertain best practice.从CONSORT到ConPhyMP声明及其他——如何确定最佳实践。
Front Pharmacol. 2023 Dec 11;14:1338710. doi: 10.3389/fphar.2023.1338710. eCollection 2023.
3
Impact of the Consolidated Standards of Reporting Trials (CONSORT) checklist on reporting of randomized clinical trials in traditional Chinese medicine.《试验报告统一标准》（CONSORT）清单对中医药随机对照试验报告的影响
J Evid Based Med. 2015 Nov;8(4):192-208. doi: 10.1111/jebm.12173.
4
Endorsement of the CONSORT statement by Chinese journals of Traditional Chinese Medicine: a survey of journal editors and review of journals' instructions for authors.中国中医期刊对CONSORT声明的认可：期刊编辑调查及期刊作者指南综述
Acupunct Med. 2016 Jun;34(3):178-83. doi: 10.1136/acupmed-2015-010870. Epub 2016 Jan 6.
5
Endorsement for improving the quality of reports on randomized controlled trials of traditional medicine journals in Korea: a systematic review.提高韩国传统医学期刊随机对照试验报告质量的认可：一项系统评价
Trials. 2014 Nov 5;15:429. doi: 10.1186/1745-6215-15-429.
6
Assessment of the reporting quality of randomized controlled trials on treatment of coronary heart disease with traditional chinese medicine from the chinese journal of integrated traditional and Western medicine: a systematic review.《中国中西医结合杂志》中关于中医药治疗冠心病随机对照试验报告质量的评估：一项系统评价
PLoS One. 2014 Jan 28;9(1):e86360. doi: 10.1371/journal.pone.0086360. eCollection 2014.
7
Reporting quality of randomized controlled trials of angina pectoris with integrated traditional Chinese and western medicine interventions: a cross-sectional study.中文译文：中西医结合心绞痛随机对照试验报告质量的横断面研究。
BMC Med Res Methodol. 2023 May 23;23(1):124. doi: 10.1186/s12874-023-01953-1.
8
Endorsement of CONSORT by Chinese medical journals: a survey of "instruction to authors".中国医学期刊对CONSORT声明的认可：对“作者须知”的一项调查
Chin J Integr Med. 2014 Jul;20(7):510-5. doi: 10.1007/s11655-014-1865-8. Epub 2014 Jun 28.
9
Ethnobotany and phytopharmacology of Pinus roxburghii Sargent: a plant review.白皮松的民族植物学和植物药理学：植物综述。
J Integr Med. 2013 Nov;11(6):371-6. doi: 10.3736/jintegrmed2013053.
10
Assessment of the reporting quality of randomized controlled trials on the treatment of diabetes mellitus with traditional chinese medicine: a systematic review.评价中医药治疗糖尿病随机对照试验报告质量的系统评价。
PLoS One. 2013 Jul 24;8(7):e70586. doi: 10.1371/journal.pone.0070586. Print 2013.
引用本文的文献
1
Isorhamnetin: Reviewing Recent Developments in Anticancer Mechanisms and Nanoformulation-Driven Delivery.异鼠李素：抗癌机制及纳米制剂驱动递送的最新进展综述
Int J Mol Sci. 2025 Jul 30;26(15):7381. doi: 10.3390/ijms26157381.
2
The Introduction of the Global Traditional, Complementary, and Integrative Healthcare (TCIH) Research Agenda on Antimicrobial Resistance and Its Added Value to the WHO and the WHO/FAO/UNEP/WOAH 2023 Research Agendas on Antimicrobial Resistance.全球传统、补充和综合卫生保健（TCIH）抗微生物药物耐药性研究议程简介及其对世界卫生组织（WHO）和世界卫生组织/联合国粮食及农业组织/联合国环境规划署/世界动物卫生组织（WHO/FAO/UNEP/WOAH）2023年抗微生物药物耐药性研究议程的附加价值。
Antibiotics (Basel). 2025 Jan 17;14(1):102. doi: 10.3390/antibiotics14010102.
3
Isorhamnetin: what is the evidence for its antitumor potential and beyond?异鼠李素：其抗肿瘤潜力及其他方面的证据有哪些？
Front Pharmacol. 2024 Apr 8;15:1309178. doi: 10.3389/fphar.2024.1309178. eCollection 2024.
本文引用的文献
1
Use of herbal medicines for the management of type 2 diabetes: A systematic review of qualitative studies.草药在 2 型糖尿病管理中的应用：定性研究的系统评价。
Complement Ther Clin Pract. 2023 Nov;53:101808. doi: 10.1016/j.ctcp.2023.101808. Epub 2023 Oct 28.
2
Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial.用中药治疗慢性阻塞性肺疾病急性加重以减少抗生素使用（王者之剑）：一项随机双盲、安慰剂对照的可行性试验。
Front Pharmacol. 2023 Sep 25;14:1221905. doi: 10.3389/fphar.2023.1221905. eCollection 2023.
3
Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners.阿育吠陀从业者管理成人2型糖尿病临床指南的制定过程。
Front Med (Lausanne). 2023 Jan 30;10:1043715. doi: 10.3389/fmed.2023.1043715. eCollection 2023.
4
Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research-The ConPhyMP-Guidelines.药理学和毒理学研究中提取物化学表征的最佳实践——ConPhyMP指南。
Front Pharmacol. 2022 Sep 13;13:953205. doi: 10.3389/fphar.2022.953205. eCollection 2022.
5
Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.中成药疏风解毒胶囊辅助治疗社区获得性肺炎：一项随机临床试验的系统评价和Meta分析
Front Pharmacol. 2022 Jul 4;13:923395. doi: 10.3389/fphar.2022.923395. eCollection 2022.
6
Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis.阿育吠陀药物在2型糖尿病管理中的有效性和安全性：一项系统评价与荟萃分析
Front Pharmacol. 2022 Jun 8;13:821810. doi: 10.3389/fphar.2022.821810. eCollection 2022.
7
Bupleuri radix for Acute Uncomplicated Respiratory Tract Infection: A Systematic Review of Randomized Controlled Trials.柴胡用于急性单纯性呼吸道感染：随机对照试验的系统评价
Front Pharmacol. 2022 Feb 4;12:787084. doi: 10.3389/fphar.2021.787084. eCollection 2021.
8
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担：系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
9
Effectiveness of Medicinal Plants for Glycaemic Control in Type 2 Diabetes: An Overview of Meta-Analyses of Clinical Trials.药用植物对2型糖尿病血糖控制的有效性：临床试验荟萃分析综述
Front Pharmacol. 2021 Nov 26;12:777561. doi: 10.3389/fphar.2021.777561. eCollection 2021.
10
The Chang Gung Research Database: Multi-institutional real-world data source for traditional Chinese medicine in Taiwan.长庚研究数据库：台湾地区中医药多机构真实世界数据来源
Pharmacoepidemiol Drug Saf. 2021 May;30(5):652-660. doi: 10.1002/pds.5208. Epub 2021 Mar 5.
Zotero 插件